| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |